This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Aditya Bardia, MD, ...
MedPage Today on MSN
ADCs continue to make first-line inroads in triple-negative breast cancer
ADCs have moved from the salvage setting into first-line treatment ...
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy. Antibody-drug conjugates (ADCs) are changing ...
Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results